Victory Capital Management Inc Catalyst Biosciences, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.76 - $8.01 $10,415 - $22,187	-2,770 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$3.5 - $8.51 $2,677 - $6,510	765 Added 38.15%	2,770 $12,000
Q4 2019 Feb 04, 2020	SELL	$4.52 - $7.91 $103 - $181	-23 Reduced 1.13%	2,005 $14,000
Q3 2019 Nov 12, 2019	BUY	$4.91 - $9.31 $9,957 - $18,880	2,028 New	2,028 $10,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.